StockData
Alamar Biosciences, Inc. logo

Alamar Biosciences, Inc. (ALMR) stock

ALMRNasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026
$30.64+0.09 (+0.29%)

Close on Nov 17, 2026Market cap $2.13BP/E –Yield –

Alamar Biosciences r&d expenses

Research and development expenses are spending on new products and technology.

Quarterly r&d expenses

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$16.17M+81.8%
Q2 FY2026Jun 30, 2026$13.82M+66.4%
Q1 FY2026Mar 31, 2026$13.02M–
Q3 FY2025Sep 30, 2025$10.21M–
Q2 FY2025Jun 30, 2025$8.90M–
Q1 FY2025Mar 31, 2025$8.30M–

More Alamar Biosciences figures

See a number that looks wrong?